Sponsor Pipeline

CoRegen, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
3
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-28 NCT07730125 Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory… Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07730125 Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory… HR-positive, HER2-negative Breast Cancer Not Yet Recruiting
Disease Areas
Breast Cancer (1) Triple-Negative Breast Cancer (1) Prostate Cancer (1)
Get alerts when CoRegen, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free